[January 17, 2019] |
|
Premier Inc. Enhances Research Offerings, Partners with Leading Life Sciences Companies
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company,
has significantly enhanced its Premier
Applied Sciences® research division with new experts,
partnerships, data and capabilities.
Premier Applied Sciences partners with industry leaders to develop,
teach, test and research care delivery practices and real-world
interventions for healthcare improvement. With recent enhancements to
its Premier Applied Sciences offering, Premier experts can now leverage
new data and analytics capabilities to conduct research that tracks the
total patient journey; identifies patients with pre-existing conditions
or diagnoses outside of the acute-care setting; and traces pre- and
post-hospital patient encounters, such as medication fills, adherence
and primary care visits.
Specifically, the enhancements include:
-
A 30 percent increase in acute care data in the Premier Healthcare
Database, which now includes HIPAA-compliant, all-payer clinical
outcomes information from more than 980 U.S. hospitals and more than
210 million unique patients, or approximately 25 percent of inpatient
discharges nationwide. One of the most comprehensive healthcare
research databases in the U.S., the Premier Healthcare Database is the
research arm of the PremierConnect®
performance improvement platform, which houses outcomes data on 45
percent of U.S. hospital discharges.
-
The addition of supplementary microbiology results data to the Premier
Healthcare Database. The data is derived from Premier's clinical
surveillance solution, powered by TheraDoc®, and includes
results, such as specimen source and observation status.
-
A new database that integrates inpatient data from the Premier
Healthcare Database with physician, facility and pharmaceutical claims
data for longitudinal patient journey research.
"Our approach to healthcare research, innovation and improvement is to
leverage the smartest intelligence available," said Denise Juliano, the newly-appointed
Group Vice President of Life Sciences, who now leads the Premier
Applied Sciences team. "Not only is a robust clinical database
imperative, but by integrating additional hospital data, microbiologic
specificity and a separate linkage with claims data, Premier has created
one of the most unique, intellectual and precise data assets available
for healthcare research in the U.S. These enhancements will support our
continued efforts to improve the cost and quality of healthcare, in
partnership with life sciences companies, academic institutions and
professional societies across the country."
Premier's research team includes epidemiologists, health economists,
health services researchers, clinicians, statisticians and other
experts. These experts leverage the Premier Healthcare Database to
conduct data, inquiry and interventional research across all therapeutic
areas, including cardiology, oncology, autoimmune diseases, infectious
diseases, pain, pulmonology, gastroenterology and urology. For example,
Premier works in partnership with life sciences companies to understand
which therapies work best in real time and develops data-driven
solutions to support them.
Examples of Premier's current work with life sciences companies include:
-
Premier's value-based partnership with Amgen, which involves a
cloud-based system to help support diagnosis and disease management of
post-fracture patients who may be appropriate for an osteoporosis
disease management program. The cloud-based system may assist in
identifying patients with fragility fractures who visit emergency
departments or are hospitalized, offer education to proiders on care
coordination and osteoporosis management, assist care coordination
workflow follow up, and assess process and specified outcomes measures
to support improvement in care. Three hospitals have agreed to
participate in a testing program to evaluate the use of the
cloud-based system in post-fracture care coordination over a six-month
period. The expected goal is to evaluate the impact on care compared
to a baseline assessment using the cloud-based system.
-
Premier's partnership
with Janssen to conduct the first and largest study of its kind
(QUANTUM AF) to address an unmet medical need for hospitalized
patients with atrial fibrillation who are at risk for ischemic stroke.
The QUANTUM AF study now includes 61 hospitals, 30 of which are
randomized and implementing locally-designed quality improvement
programs to improve the use of guideline-directed oral anticoagulation
in patients with atrial fibrillation who at risk for stroke. The other
31 hospitals are randomized as the control.
-
Premier's collaboration
with Merck, which was initially announced in 2016, to co-develop
and test solutions to help improve patient care. In one project, the
companies are developing a population health improvement program that
includes a cloud-based
application, provider education, and process and outcomes measures
to help reduce the recurrence of Clostridium difficile infection (C.
diff) by improving follow-up and management. It will be tested
across five provider sites. In another project, the companies are
working on a chronic disease model to identify and treat patients with
type 1 and type 2 diabetes at risk for hypoglycemia and osteoporosis,
which will be tested at two health systems.
"I am impressed each day by the work of the Premier Applied Sciences
team and the companies we are working with," Juliano added. "We all
share a common goal: to get the answers to tomorrow's healthcare
questions today. It's about meeting the needs of our health system
members as the industry continues to evolve and shift toward value-based
care and payment. Premier's access to real-world data and analytics,
leading industry innovators, a proven improvement methodology and
seasoned experts allow us to get deep clinical insights on what needs to
be done to make healthcare better in the future."
With nearly two decades of research, Premier researchers have authored
more than 95 articles in peer-reviewed publications. Additionally, the
Premier Healthcare Database, which provides objective evidence- and
population-based analyses of drugs, devices, treatments, disease states,
resource utilization, epidemiology, healthcare costs and clinical
outcomes, has been featured in more than 440 peer-reviewed publications.
Forward-Looking Statements Matters discussed in this release
that are not statements of historical or current facts, are
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Forward-looking statements may
involve known and unknown risks, uncertainties and other factors that
may cause the actual results, performance or achievements of Premier to
be materially different from historical results or from any future
results or projections expressed or implied by such forward-looking
statements. Accordingly, readers should not place undue reliance on any
forward-looking statements. In addition to statements that explicitly
describe such risks and uncertainties, readers are urged to consider
statements in the conditional or future tenses or that include terms
such as "believes," "belief," "expects," "estimates," "intends,"
"anticipates" or "plans" to be uncertain and forward-looking.
Forward-looking statements may include comments as to Premier's beliefs
and expectations as to future events and trends affecting its business
and are necessarily subject to uncertainties, many of which are outside
Premier's control. More information on potential factors that could
affect Premier's financial results is included from time to time in the
"Forward-Looking Statements," "Risk Factors" and "Management's
Discussion and Analysis of Financial Condition and Results of
Operations" sections of Premier's periodic and current filings with the
SEC (News - Alert) and available on Premier's website at investors.premierinc.com.
Forward-looking statements speak only as of the date they are made.
Premier undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information,
future events or otherwise that occur after that date.
About Premier Inc. Premier Inc. (NASDAQ: PINC) is a leading
healthcare improvement company, uniting an alliance of more than 4,000
U.S. hospitals and health systems and approximately 165,000 other
providers and organizations to transform healthcare. With integrated
data and analytics, collaboratives, supply chain solutions, and
consulting and other services, Premier enables better care and outcomes
at a lower cost. Premier plays a critical role in the rapidly evolving
healthcare industry, collaborating with members to co-develop long-term
innovations that reinvent and improve the way care is delivered to
patients nationwide. Headquartered in Charlotte, N.C., Premier is
passionate about transforming American healthcare. Please visit
Premier's news and investor sites on www.premierinc.com;
as well as Twitter,
Facebook,
LinkedIn,
YouTube,
Instagram
and Premier's
blog for more information about the company.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190117005780/en/
[ Back To TMCnet.com's Homepage ]
|